Zhejiang Medicine Co., Ltd.
Zhejiang Medicine Co., Ltd., commonly referred to as ZMC, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 1995, the company has made significant strides in the development and production of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions, ZMC is dedicated to innovation and quality, offering unique formulations that cater to both domestic and international markets. The company has achieved notable milestones, including certifications that underscore its commitment to excellence in manufacturing practices. Renowned for its robust portfolio, ZMC continues to solidify its market position through strategic partnerships and a focus on research and development, making it a key contributor to the global healthcare landscape.
DitchCarbon Score
How does Zhejiang Medicine Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Medicine Co., Ltd.'s score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Medicine Co., Ltd.'s reported carbon emissions
Zhejiang Medicine Co., Ltd., headquartered in China, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their carbon emissions in kg CO2e, nor any documented initiatives aimed at reducing their carbon footprint. The absence of emissions data and reduction commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change, and it is anticipated that Zhejiang Medicine will align with industry standards in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhejiang Medicine Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
